RhumbLine Advisers’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.6M | Buy |
|
|||||
|
2025
Q1 | $3.42M | Sell |
|
|||||
|
2024
Q4 | $6.44M | Sell |
|
|||||
|
2024
Q3 | $7.78M | Sell |
|
|||||
|
2024
Q2 | $7.53M | Buy |
|
|||||
|
2024
Q1 | $5.72M | Sell |
|
|||||
|
2023
Q4 | $5.09M | Sell |
|
|||||
|
2023
Q3 | $3.6M | Sell |
|
|||||
|
2023
Q2 | $4.3M | Sell |
|
|||||
|
2023
Q1 | $7.21M | Sell |
|
|||||
|
2022
Q4 | $8.52M | Buy |
|
|||||
|
2022
Q3 | $8.67M | Buy |
|
|||||
|
2022
Q2 | $10.5M | Buy |
|
|||||
|
2022
Q1 | $19M | Buy |
|
|||||
|
2021
Q4 | $24.5M | Buy |
|
|||||
|
2021
Q3 | $19.2M | Buy |
|
|||||
|
2021
Q2 | $5.77M | Sell |
|
|||||
|
2021
Q1 | $5.57M | Sell |
|
|||||
|
2020
Q4 | $6.31M | Sell |
|
|||||
|
2020
Q3 | $7.56M | Sell |
|
|||||
|
2020
Q2 | $6.83M | Sell |
|
|||||
|
2020
Q1 | $5.21M | Buy |
|
|||||
|
2019
Q4 | $4.75M | Buy |
|
|||||
|
2019
Q3 | $4.52M | Sell |
|
|||||
|
2019
Q2 | $5.02M | Buy |
|
|||||
|
2019
Q1 | $4.33M | Buy |
|
|||||
|
2018
Q4 | $2.58M | Buy |
|
|||||
|
2018
Q3 | $1.96M | Buy |
|
|||||
|
2018
Q2 | $943K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $20K | Buy |
|
|||||
|
2016
Q4 | $33K | Sell |
|
|||||
|
2016
Q3 | $127K | Buy |
|
|||||
|
2016
Q2 | $123K | Buy |
|
|||||
|
2016
Q1 | $137K | Buy |
|
|||||
|
2015
Q4 | $184K | Buy |
|
|||||
|
2015
Q3 | $124K | Buy |
|
|||||
|
2015
Q2 | $145K | Buy |
|